New combo treatment aims to quiet suicidal thoughts fast
NCT ID NCT07396220
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding a brief therapy to esketamine nasal spray works better than the spray alone for reducing suicidal thoughts in people with hard-to-treat depression. About 56 adults aged 18 to 70 with ongoing suicidal thoughts will take part. The goal is to see if the combined approach leads to quicker relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UC San Diego Health - 4S Ranch
San Diego, California, 92127, United States